Two new gene therapies could present cure for sickle cell disease, but access is an obstacle

High costs and the complexity of administering the drugs may keep them out of reach of patients in need

Related Keywords

Canada ,Saskatchewan ,Manitoba ,Saskatoon ,United Kingdom ,Toronto ,Ontario ,Calgary ,Alberta ,United States ,British ,Canadians ,Lanre Tunji Ajayi ,Lance Archer ,Sven Kili ,Ronald Cohn ,Greg Guilcher ,Tyler Wenzel ,Casgevy To Health Canada ,Centre For Commercialization Of Regenerative Medicine ,Vertex Pharmaceuticals ,Health Canada ,Sickle Cell Awareness Group Of Ontario ,Blood Disorders Research Program ,University Of Calgary ,University Of Saskatchewan ,Log Increate Free ,Massachusetts Based Bluebird Bio ,Regenerative Medicine ,Childhood Cancer ,Sickle Cell Awareness Group ,Patient ,Gene ,Disease ,Treatment ,People ,Casgevy ,Condition ,Crispr ,